REVIEW: A REPORT ON BIOLOGICS AND BIOSIMILARS

Vipasha Patyal*, Tanuj, Kavita Pathania, Neha

Biologics are a special kind of medicine that is made using living cells like bacteria, yeast, or animal cells. They are mainly used to treat serious diseases such as cancer, diabetes, and problems where the immune system attacks the body. Unlike normal medicines, biologics are more complicated to make because they involve advanced technology. That’s why they are usually more expensive and harder to produce. But even though they are costly, they work very well and have helped treat many difficult diseases effectively. When the patents of these biologic medicines expire, similar medicines called Biosimilars are developed. Biosimilars are almost the same as the original biologics in terms of safety, quality, and effectiveness. However, they are not exactly identical because they are made from living systems. To ensure they work properly, Biosimilars go through strict testing and approval processes before they are available for use. In this project we talk about the challenges in making them, like keeping the quality high and making sure they don’t cause unwanted reactions in the body. One of the biggest benefits of biosimilars is that they cost less than original biologics. Because of this, more patients can afford important treatments, especially in places where healthcare is expensive. Even though some healthcare professionals have concerns about their use, awareness and proper knowledge can improve trust in Biosimilars. In conclusion, biologics and Biosimilars are important in modern healthcare. They not only give effective treatment but also make advanced medicines easier to get and more affordable for patients.